+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
CAPRIHANS CAPRIHANS

Caprihans India Share Price

₹89.55 -1.45 (-1.59%)
35.51% Fall from 52W High

20 Nov, 2026 10:15 AM (IST)

Caprihans India live price: ₹89.55. It opened at ₹90 vs previous close ₹91; intraday high/low: ₹90/₹90. The 50 & 200 DMA stand at ₹99.80/₹96.20.

Caprihans India Performance

  • Today's Low
  • ₹90
  • Today's High
  • ₹90
  • 52 Week Low
  • ₹50
  • 52 Week High
  • ₹139
  • Open Price₹90
  • Previous Close₹91
  • Volume250
  • 50 DMA₹99.80
  • 100 DMA₹97.80
  • 200 DMA₹96.20

Caprihans India Chart

Investment Returns

  • Over 1 Month -3.81%
  • Over 3 Month -33.17%
  • Over 6 Month + 22.97%
  • Over 1 Year -10.23%

Smart Investing Starts Here Start SIP with Caprihans India for Steady Growth!

Invest Now

Caprihans India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -12.3
  • PEG Ratio
  • -0.2
  • Market Cap Cr
  • 131
  • P/B Ratio
  • 0.3
  • Average True Range
  • 3.1
  • EPS
  • -7.3
  • Dividend Yield
  • 0
  • MACD Signal
  • -3.2
  • RSI
  • 37.61
  • MFI
  • 32.53

Latest Stock News Updates

Caprihans India Ltd-$ - 509486 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Caprihans India Limited has informed the Exchange about publication of Unaudited Financial Results for the quarter ended on 30 September 2026 in Financial Express (All editions) and Loksatta (Pune edition) on 01 November 2026.

Caprihans India Ltd-$ - 509486 - Standalone And Consolidated Unaudited Financial Results For The Quarter And Six Months Ended On 30 September 2026 Along With Limited Review Report

The Board of Directors of Caprihans India Limited in their Meeting held on 30 October 2026 has approved and taken on record Unaudited Financial Results (Standalone & Consolidated) for the period ended on 30 September 2026. The Limited Review Report issued by the Statutory Auditors of the Company is also enclosed herewith.

Caprihans India Ltd-$ - 509486 - Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results Along With Limited Review Report For The Period Ended On 30 September 2026

The Board of Directors of Caprihans India Limited in their meeting held on Friday, 30 October 2026 have approved and taken on record (A) Standalone and Consolidated Unaudited Financial Results of the Company for the period ended on 30 September 2026 and (B) Limited Review Report issued by the Statutory Auditors of the Company.

Caprihans India Financials

Caprihans India Technicals

EMA & SMA

Current Price
₹89.55
-1.45 (-1.59%)
pointer
  • Bearish Moving Average 15
  • Bullish Moving Average 1
  • 20 Day
  • ₹96.30
  • 50 Day
  • ₹99.80
  • 100 Day
  • ₹97.80
  • 200 Day
  • ₹96.20

Resistance and Support

89.58 Pivot Speed
  • R3 97.00
  • R2 95.80
  • R1 93.40
  • S1 89.80
  • S2 88.60
  • S3 86.20

Caprihans India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-30 Quarterly Results
2026-08-10 Quarterly Results
2026-05-25 Audited Results
2026-02-10 Quarterly Results
2025-11-12 Quarterly Results

Caprihans India Shareholding Pattern

55.99%
44%
0.01%
0%

About Caprihans India

Caprihans India is engaged in the business of pharmaceutical packaging and manufacturing of rigid and flexible PVC films, PVdC coated films, plastic extruded products, alu alu foils and other allied products. View More
  • NSE Symbol
  • CAPRIHANS
  • BSE Symbol
  • 509486
  • ISIN
  • INE479A01018

Similar Stocks to Caprihans India

Caprihans India FAQs

Caprihans India share price is ₹89 As on 20 November, 2026 | 10:08

The Market Cap of Caprihans India is ₹131 Cr As on 20 November, 2026 | 10:08

The P/E ratio of Caprihans India is -12.3 As on 20 November, 2026 | 10:08

The PB ratio of Caprihans India is 0.3 As on 20 November, 2026 | 10:08

The 52 week High & Low of Caprihans India is ₹138.8/₹50.3 respectively As on 20 November, 2026 | 10:08

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23